Emerald Bioscience OTCQB : EMBI

Emerald Bioscience OTCQB : EMBI

Company Overview

Emerald Bioscience Inc. is a biopharmaceutical company focused on the discovery and development of first-in-class molecules with strong clinical and commercial differentiation for conditions with significant, global, unmet medical needs. With proprietary technology licensed from the University of Mississippi, the Company is developing novel ways to deliver its synthetic cannabinoid-derived molecules for specific indications with the aim of optimizing therapeutic benefit. The Company’s aim is to clinically develop multiple proprietary compounds alone or in combination with corporate partners.

Latest Financial Results

Q3 2020

Quarter Ended Sep 30, 2020

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

Investor Contact Information


Emerald Bioscience, Inc.
5910 Pacific Center Blvd.
Suite 320
San Diego, CA 92121

Investor Relations

EMBI Investor Relations
T: 949-396-0330

Transfer Agent

ClearTrust, LLC
16540 Pointe Village Dr.
Suite 210
Lutz, FL 33558
T: 813-235-4490